{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:47:45Z","timestamp":1793119665690,"version":"4.5.0"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente 2022-2024"],"award-info":[{"award-number":["Ricerca Corrente 2022-2024"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004769","name":"Universit\u00e0 degli Studi di Pavia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004769","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Autoimmune encephalitis is a relatively novel nosological entity characterized by an immune-mediated damage of the central nervous system. While originally described as a paraneoplastic inflammatory phenomenon affecting limbic structures, numerous instances of non-paraneoplastic pathogenesis, as well as extra-limbic involvement, have been characterized. Given the wide spectrum of insidious clinical presentations ranging from cognitive impairment to psychiatric symptoms or seizures, it is crucial to raise awareness about this disease category. In fact, an early diagnosis can be dramatically beneficial for the prognosis both to achieve an early therapeutic intervention and to detect a potential underlying malignancy. In this scenario, the radiologist can be the first to pose the hypothesis of autoimmune encephalitis and refer the patient to a comprehensive diagnostic work-up \u2013 including clinical, serological, and neurophysiological assessments.<\/jats:p>\n                  <jats:p>In this article, we illustrate the main radiological characteristics of autoimmune encephalitis and its subtypes, including the typical limbic presentation, the features of extra-limbic involvement, and also peculiar imaging findings. In addition, we review the most relevant alternative diagnoses that should be considered, ranging from other encephalitides to neoplasms, vascular conditions, and post-seizure alterations. Finally, we discuss the most appropriate imaging diagnostic work-up, also proposing a suggested MRI protocol.<\/jats:p>","DOI":"10.1007\/s00234-024-03318-x","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T03:02:37Z","timestamp":1710903757000},"page":"653-675","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Autoimmune encephalitis: what the radiologist needs to know"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3379-9958","authenticated-orcid":false,"given":"Francesco","family":"Sanvito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pichiecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Rebella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Resaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Morbelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Caverzasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Asteggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Businaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Masciocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Castellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Franciotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Gastaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Roccatagliata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"3318_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3988\/jcn.2016.12.1.1","volume":"12","author":"E Lancaster","year":"2016","unstructured":"Lancaster E (2016) The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol 12:1\u201313. https:\/\/doi.org\/10.3988\/jcn.2016.12.1.1","journal-title":"J Clin Neurol"},{"key":"3318_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4997\/JRCPE.2019.407","volume":"49","author":"JA Goodfellow","year":"2019","unstructured":"Goodfellow JA, Mackay GA (2019) Autoimmune encephalitis. J R Coll Physicians Edinb 49:287\u2013294. https:\/\/doi.org\/10.4997\/JRCPE.2019.407","journal-title":"J R Coll Physicians Edinb"},{"key":"3318_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ana.25131","volume":"83","author":"D Dubey","year":"2018","unstructured":"Dubey D, Pittock SJ, Kelly CR et al (2018) Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol 83:166\u2013177. https:\/\/doi.org\/10.1002\/ana.25131","journal-title":"Ann Neurol"},{"key":"3318_CR4","doi-asserted-by":"publisher","unstructured":"H\u00e9bert J, Riche B, Vogrig A, et al (2020) Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France. Neurol Neuroimmunol Neuroinflammation 7:. https:\/\/doi.org\/10.1212\/NXI.0000000000000883","DOI":"10.1212\/NXI.0000000000000883"},{"key":"3318_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2217\/fnl-2019-0026","volume":"15","author":"L Zuliani","year":"2020","unstructured":"Zuliani L, Zoccarato M (2020) Open issues in antibody-mediated encephalitis. Future Neurol 15:2\u20135. https:\/\/doi.org\/10.2217\/fnl-2019-0026","journal-title":"Future Neurol"},{"key":"3318_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamaneurol.2022.4251","volume":"80","author":"EP Flanagan","year":"2023","unstructured":"Flanagan EP, Geschwind MD, Lopez-Chiriboga AS et al (2023) Autoimmune Encephalitis Misdiagnosis in Adults. JAMA Neurol 80:30\u201339. https:\/\/doi.org\/10.1001\/jamaneurol.2022.4251","journal-title":"JAMA Neurol"},{"key":"3318_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/brain\/91.3.481","volume":"91","author":"JA Corsellis","year":"1968","unstructured":"Corsellis JA, Goldberg GJ, Norton AR (1968) \u201cLimbic encephalitis\u201d and its association with carcinoma. Brain 91:481\u2013496. https:\/\/doi.org\/10.1093\/brain\/91.3.481","journal-title":"Brain"},{"key":"3318_CR8","doi-asserted-by":"publisher","first-page":"785","DOI":"10.7326\/0003-4819-96-6-785_1","volume":"96","author":"M Markham","year":"1982","unstructured":"Markham M, Abeloff MD (1982) Small-cell lung cancer and limbic encephalitis. Ann Intern Med 96:785","journal-title":"Ann Intern Med"},{"key":"3318_CR9","doi-asserted-by":"publisher","unstructured":"Gultekin SH, Rosenfeld MR, Voltz R, et al (2000) Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123 ( Pt 7:1481\u20131494. https:\/\/doi.org\/10.1093\/brain\/123.7.1481","DOI":"10.1093\/brain\/123.7.1481"},{"key":"3318_CR10","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","volume":"9","author":"M Lai","year":"2010","unstructured":"Lai M, Huijbers MGM, Lancaster E et al (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9:776\u2013785. https:\/\/doi.org\/10.1016\/S1474-4422(10)70137-X","journal-title":"Lancet Neurol"},{"key":"3318_CR11","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awq213","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Alexander S, Waters P et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia. Brain 133:2734\u20132748. https:\/\/doi.org\/10.1093\/brain\/awq213","journal-title":"Brain"},{"key":"3318_CR12","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3174\/ajnr.A5086","volume":"38","author":"BP Kelley","year":"2017","unstructured":"Kelley BP, Patel SC, Marin HL et al (2017) Autoimmune encephalitis: Pathophysiology and imaging review of an overlooked diagnosis. Am J Neuroradiol 38:1070\u20131078. https:\/\/doi.org\/10.3174\/ajnr.A5086","journal-title":"Am J Neuroradiol"},{"key":"3318_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","volume":"8","author":"E Lancaster","year":"2012","unstructured":"Lancaster E, Dalmau J (2012) Neuronal autoantigens-pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 8:380\u2013390. https:\/\/doi.org\/10.1038\/nrneurol.2012.99","journal-title":"Nat Rev Neurol"},{"key":"3318_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2021.673339","volume":"12","author":"E Sechi","year":"2021","unstructured":"Sechi E, Flanagan EP (2021) Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management. Front Neurol 12:1\u201318. https:\/\/doi.org\/10.3389\/fneur.2021.673339","journal-title":"Front Neurol"},{"key":"3318_CR15","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","volume":"124","author":"F Graus","year":"2001","unstructured":"Graus F, Keime-Guibert F, Re\u00f1e R et al (2001) Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 124:1138\u20131148. https:\/\/doi.org\/10.1093\/brain\/124.6.1138","journal-title":"Brain"},{"key":"3318_CR16","doi-asserted-by":"publisher","unstructured":"Hermetter C, Fazekas F, Hochmeister S (2018) Systematic review: Syndromes, early diagnosis, and treatment in autoimmune encephalitis. Front Neurol 9:. https:\/\/doi.org\/10.3389\/fneur.2018.00706","DOI":"10.3389\/fneur.2018.00706"},{"key":"3318_CR17","doi-asserted-by":"publisher","unstructured":"Graus F, Vogrig A, Mu\u00f1iz-Castrillo S, et al (2021) Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. Neurol Neuroimmunol neuroinflammation 8:. https:\/\/doi.org\/10.1212\/NXI.0000000000001014","DOI":"10.1212\/NXI.0000000000001014"},{"key":"3318_CR18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9.A","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol - NIH 15:391\u2013404. https:\/\/doi.org\/10.1016\/S1474-4422(15)00401-9.A","journal-title":"Lancet Neurol - NIH"},{"key":"3318_CR19","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/brain\/awh203","volume":"127","author":"J Dalmau","year":"2004","unstructured":"Dalmau J, Graus F, Villarejo A et al (2004) Clinical analysis of anti-Ma2-associated encephalitis. Brain 127:1831\u20131844. https:\/\/doi.org\/10.1093\/brain\/awh203","journal-title":"Brain"},{"key":"3318_CR20","doi-asserted-by":"publisher","unstructured":"Sonderen A Van, Coenders EC, Sanchez E, et al (2016) Anti-LGI1 encephalitis https:\/\/doi.org\/10.1212\/WNL.0000000000003173","DOI":"10.1212\/WNL.0000000000003173"},{"key":"3318_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","volume":"87","author":"A van Sonderen","year":"2016","unstructured":"van Sonderen A, Ari\u00f1o H, Petit-Pedrol M et al (2016) The clinical spectrum of Caspr2 antibody-associated disease. Neurology 87:521\u2013528. https:\/\/doi.org\/10.1212\/WNL.0000000000002917","journal-title":"Neurology"},{"key":"3318_CR22","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","volume":"84","author":"R H\u00f6ftberger","year":"2015","unstructured":"H\u00f6ftberger R, van Sonderen A, Leypoldt F et al (2015) Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients. Neurology 84:2403\u20132412. https:\/\/doi.org\/10.1212\/WNL.0000000000001682","journal-title":"Neurology"},{"key":"3318_CR23","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1093\/brain\/awac166","volume":"145","author":"W-J Lee","year":"2022","unstructured":"Lee W-J, Lee H-S, Kim D-Y et al (2022) Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes. Brain 145:3509\u20133521. https:\/\/doi.org\/10.1093\/brain\/awac166","journal-title":"Brain"},{"key":"3318_CR24","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/ene.13661","volume":"25","author":"F Graus","year":"2018","unstructured":"Graus F, Escudero D, Oleaga L et al (2018) Syndrome and outcome of antibody-negative limbic encephalitis. Eur J Neurol 25:1011\u20131016. https:\/\/doi.org\/10.1111\/ene.13661","journal-title":"Eur J Neurol"},{"key":"3318_CR25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1474-4422(23)00083-2","volume":"22","author":"J Dalmau","year":"2023","unstructured":"Dalmau J, Graus F (2023) Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease. Lancet Neurol 22:529\u2013540. https:\/\/doi.org\/10.1016\/S1474-4422(23)00083-2","journal-title":"Lancet Neurol"},{"key":"3318_CR26","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/jnnp-2020-325302","volume":"92","author":"H Abboud","year":"2021","unstructured":"Abboud H, Probasco J, Irani SR et al (2021) Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management. J Neurol Neurosurg Psychiatry 92:897\u2013907. https:\/\/doi.org\/10.1136\/jnnp-2020-325302","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3318_CR27","doi-asserted-by":"publisher","first-page":"e1376","DOI":"10.1212\/WNL.0000000000207478","volume":"101","author":"L Cacciaguerra","year":"2023","unstructured":"Cacciaguerra L, Redenbaugh V, Chen JJ et al (2023) Timing and Predictors of T2-Lesion Resolution in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Neurology 101:e1376\u2013e1381. https:\/\/doi.org\/10.1212\/WNL.0000000000207478","journal-title":"Neurology"},{"key":"3318_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00005792-199203000-00001","volume":"71","author":"J Dalmau","year":"1992","unstructured":"Dalmau J, Graus F, Rosenblum MK, Posner JB (1992) Anti-Hu\u2013associated paraneoplastic encephalomyelitis\/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 71:59\u201372. https:\/\/doi.org\/10.1097\/00005792-199203000-00001","journal-title":"Medicine (Baltimore)"},{"key":"3318_CR29","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s00415-009-5407-9","volume":"257","author":"CP Gilmore","year":"2010","unstructured":"Gilmore CP, Elliott I, Auer D, Maddison P (2010) Diffuse cerebellar MR imaging changes in anti-Yo positive paraneoplastic cerebellar degeneration. J Neurol 257:490\u2013491","journal-title":"J Neurol"},{"key":"3318_CR30","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/acn3.328","volume":"3","author":"A Venkatraman","year":"2016","unstructured":"Venkatraman A, Opal P (2016) Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review. Ann Clin Transl Neurol 3:655\u2013663. https:\/\/doi.org\/10.1002\/acn3.328","journal-title":"Ann Clin Transl Neurol"},{"key":"3318_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.clineuro.2018.05.010","volume":"170","author":"N Dericioglu","year":"2018","unstructured":"Dericioglu N, Gocmen R, Tan E (2018) Paraneoplastic striatal encephalitis and myelitis associated with anti-CV2\/CRMP-5 antibodies in a patient with small cell lung cancer. Clin Neurol Neurosurg 170:117\u2013119. https:\/\/doi.org\/10.1016\/j.clineuro.2018.05.010","journal-title":"Clin Neurol Neurosurg"},{"key":"3318_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1136\/jnnp.2008.159483","volume":"81","author":"D Psimaras","year":"2010","unstructured":"Psimaras D, Carpentier AF, Rossi C (2010) Cerebrospinal fluid study in paraneoplastic syndromes. J Neurol Neurosurg Psychiatry 81:42\u201345. https:\/\/doi.org\/10.1136\/jnnp.2008.159483","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3318_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.neurol.2017.11.004","volume":"174","author":"J Honnorat","year":"2018","unstructured":"Honnorat J, Plazat LO (2018) Autoimmune encephalitis and psychiatric disorders. Rev Neurol (Paris) 174:228\u2013236. https:\/\/doi.org\/10.1016\/j.neurol.2017.11.004","journal-title":"Rev Neurol (Paris)"},{"key":"3318_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.inat.2020.100980","volume":"23","author":"ADP Neto","year":"2021","unstructured":"Neto ADP, de Aquino BCV, de Morais Brito PS et al (2021) ANTI-MA2 encephalitis mimicking diencephalic demyelinating syndrome. Interdiscip Neurosurg 23:100980. https:\/\/doi.org\/10.1016\/j.inat.2020.100980","journal-title":"Interdiscip Neurosurg"},{"key":"3318_CR35","doi-asserted-by":"publisher","unstructured":"119. Dade M, Berzero G, Izquierdo C, et al (2020) Neurological Syndromes Associated with Anti-GAD Antibodies. Int J Mol Sci 21:. https:\/\/doi.org\/10.3390\/ijms21103701","DOI":"10.3390\/ijms21103701"},{"key":"3318_CR36","doi-asserted-by":"publisher","first-page":"10199","DOI":"10.1038\/s41598-021-89010-z","volume":"11","author":"E Conde-Blanco","year":"2021","unstructured":"Conde-Blanco E, Pascual-Diaz S, Carre\u00f1o M et al (2021) Volumetric and shape analysis of the hippocampus in temporal lobe epilepsy with GAD65 antibodies compared with non-immune epilepsy. Sci Rep 11:10199. https:\/\/doi.org\/10.1038\/s41598-021-89010-z","journal-title":"Sci Rep"},{"key":"3318_CR37","doi-asserted-by":"publisher","unstructured":"Simard C, Vogrig A, Joubert B, et al (2020) Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies. Neurol Neuroimmunol neuroinflammation 7:. https:\/\/doi.org\/10.1212\/NXI.0000000000000699","DOI":"10.1212\/NXI.0000000000000699"},{"key":"3318_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ana.20529","volume":"58","author":"SJ Pittock","year":"2005","unstructured":"Pittock SJ, Lucchinetti CF, Parisi JE et al (2005) Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol 58:96\u2013107. https:\/\/doi.org\/10.1002\/ana.20529","journal-title":"Ann Neurol"},{"key":"3318_CR39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ana.24872","volume":"81","author":"A Gadoth","year":"2017","unstructured":"Gadoth A, Kryzer TJ, Fryer J et al (2017) Microtubule-associated protein 1B: Novel paraneoplastic biomarker. Ann Neurol 81:266\u2013277. https:\/\/doi.org\/10.1002\/ana.24872","journal-title":"Ann Neurol"},{"key":"3318_CR40","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3988\/jcn.2020.16.4.530","volume":"16","author":"X Sun","year":"2020","unstructured":"Sun X, Tan J, Sun H et al (2020) Anti-SOX1 Antibodies in Paraneoplastic Neurological Syndrome. J Clin Neurol 16:530\u2013546. https:\/\/doi.org\/10.3988\/jcn.2020.16.4.530","journal-title":"J Clin Neurol"},{"key":"3318_CR41","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1600-0404.2011.01572.x","volume":"125","author":"O Stich","year":"2012","unstructured":"Stich O, Klages E, Bischler P et al (2012) SOX1 antibodies in sera from patients with paraneoplastic neurological syndromes. Acta Neurol Scand 125:326\u2013331. https:\/\/doi.org\/10.1111\/j.1600-0404.2011.01572.x","journal-title":"Acta Neurol Scand"},{"key":"3318_CR42","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s00415-022-11523-y","volume":"270","author":"M Vabanesi","year":"2023","unstructured":"Vabanesi M, Pinto A-L, Vogrig A et al (2023) SOX1 antibody-related paraneoplastic neurological syndromes: clinical correlates and assessment of laboratory diagnostic techniques. J Neurol 270:1691\u20131701. https:\/\/doi.org\/10.1007\/s00415-022-11523-y","journal-title":"J Neurol"},{"key":"3318_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1056\/NEJMoa1816721","volume":"381","author":"C Mandel-Brehm","year":"2019","unstructured":"Mandel-Brehm C, Dubey D, Kryzer TJ et al (2019) Kelch-like Protein 11 Antibodies in Seminoma-Associated Paraneoplastic Encephalitis. N Engl J Med 381:47\u201354. https:\/\/doi.org\/10.1056\/NEJMoa1816721","journal-title":"N Engl J Med"},{"key":"3318_CR44","doi-asserted-by":"publisher","first-page":"fcab185","DOI":"10.1093\/braincomms\/fcab185","volume":"3","author":"A Vogrig","year":"2021","unstructured":"Vogrig A, P\u00e9ricart S, Pinto A-L et al (2021) Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis. Brain Commun 3:fcab185. https:\/\/doi.org\/10.1093\/braincomms\/fcab185","journal-title":"Brain Commun"},{"key":"3318_CR45","doi-asserted-by":"publisher","first-page":"e1677","DOI":"10.1212\/WNL.0000000000006435","volume":"91","author":"E Basal","year":"2018","unstructured":"Basal E, Zalewski N, Kryzer TJ et al (2018) Paraneoplastic neuronal intermediate filament autoimmunity. Neurology 91:e1677\u2013e1689. https:\/\/doi.org\/10.1212\/WNL.0000000000006435","journal-title":"Neurology"},{"key":"3318_CR46","doi-asserted-by":"publisher","first-page":"e815","DOI":"10.1212\/WNL.0000000000007971","volume":"93","author":"A Zekeridou","year":"2019","unstructured":"Zekeridou A, Kryzer T, Guo Y et al (2019) Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity. Neurology 93:e815\u2013e822. https:\/\/doi.org\/10.1212\/WNL.0000000000007971","journal-title":"Neurology"},{"key":"3318_CR47","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/ana.26320","volume":"91","author":"A Zekeridou","year":"2022","unstructured":"Zekeridou A, Yang B, Lennon VA et al (2022) Anti-Neuronal Nuclear Antibody 3 Autoimmunity Targets Dachshund Homolog 1. Ann Neurol 91:670\u2013675. https:\/\/doi.org\/10.1002\/ana.26320","journal-title":"Ann Neurol"},{"key":"3318_CR48","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1212\/01.wnl.0000041495.87539.98","volume":"60","author":"F Bernal","year":"2003","unstructured":"Bernal F, Shams\u2019ili S, Rojas I, et al (2003) Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin\u2019s disease. Neurology 60:230\u2013234. https:\/\/doi.org\/10.1212\/01.wnl.0000041495.87539.98","journal-title":"Neurology"},{"key":"3318_CR49","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/acn3.396","volume":"4","author":"MH van Coevorden-Hameete","year":"2017","unstructured":"van Coevorden-Hameete MH, van Beuningen SFB, Perrenoud M et al (2017) Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes. Ann Clin Transl Neurol 4:680\u2013686. https:\/\/doi.org\/10.1002\/acn3.396","journal-title":"Ann Clin Transl Neurol"},{"key":"3318_CR50","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/jnnp-2021-326656","volume":"93","author":"C Valencia-Sanchez","year":"2022","unstructured":"Valencia-Sanchez C, Knight AM, Hammami MB et al (2022) Characterisation of TRIM46 autoantibody-associated paraneoplastic neurological syndrome. J Neurol Neurosurg Psychiatry 93:196\u2013200. https:\/\/doi.org\/10.1136\/jnnp-2021-326656","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3318_CR51","doi-asserted-by":"publisher","first-page":"e954","DOI":"10.1212\/WNL.0000000000008061","volume":"93","author":"JA Honorat","year":"2019","unstructured":"Honorat JA, Lopez-Chiriboga AS, Kryzer TJ et al (2019) Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG. Neurology 93:e954\u2013e963. https:\/\/doi.org\/10.1212\/WNL.0000000000008061","journal-title":"Neurology"},{"key":"3318_CR52","doi-asserted-by":"publisher","unstructured":"Miske R, Scharf M, Stark P, et al (2021) Autoantibodies Against the Purkinje Cell Protein RGS8 in Paraneoplastic Cerebellar Syndrome. Neurol Neuroimmunol neuroinflammation 8:. https:\/\/doi.org\/10.1212\/NXI.0000000000000987","DOI":"10.1212\/NXI.0000000000000987"},{"key":"3318_CR53","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1093\/brain\/awab153","volume":"144","author":"S Mu\u00f1iz-Castrillo","year":"2021","unstructured":"Mu\u00f1iz-Castrillo S, Hedou JJ, Ambati A et al (2021) Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis. Brain 144:2709\u20132721. https:\/\/doi.org\/10.1093\/brain\/awab153","journal-title":"Brain"},{"key":"3318_CR54","doi-asserted-by":"publisher","unstructured":"Do L-D, Moritz CP, Mu\u00f1iz-Castrillo S, et al (2021) Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic Diseases. Neurol Neuroimmunol neuroinflammation 8:. https:\/\/doi.org\/10.1212\/NXI.0000000000001032","DOI":"10.1212\/NXI.0000000000001032"},{"key":"3318_CR55","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.24881","volume":"81","author":"EP Flanagan","year":"2017","unstructured":"Flanagan EP, Hinson SR, Lennon VA et al (2017) Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients. Ann Neurol 81:298\u2013309. https:\/\/doi.org\/10.1002\/ana.24881","journal-title":"Ann Neurol"},{"key":"3318_CR56","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1212\/01.wnl.0000113749.77217.01","volume":"62","author":"L Bataller","year":"2004","unstructured":"Bataller L, Wade DF, Graus F et al (2004) Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Neurology 62:778\u2013782. https:\/\/doi.org\/10.1212\/01.wnl.0000113749.77217.01","journal-title":"Neurology"},{"key":"3318_CR57","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.21037\/tlcr-21-989","volume":"11","author":"J Pozas","year":"2022","unstructured":"Pozas J, Albarr\u00e1n-Fern\u00e1ndez V, Gonz\u00e1lez-Campo L et al (2022) Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report. Transl lung cancer Res 11:1497\u20131502","journal-title":"Transl lung cancer Res"},{"key":"3318_CR58","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/ana.26482","volume":"92","author":"SR Hinson","year":"2022","unstructured":"Hinson SR, Honorat JA, Grund EM et al (2022) Septin-5 and -7-IgGs: Neurologic, Serologic, and Pathophysiologic Characteristics. Ann Neurol 92:1090\u20131101. https:\/\/doi.org\/10.1002\/ana.26482","journal-title":"Ann Neurol"},{"key":"3318_CR59","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091\u20131098. https:\/\/doi.org\/10.1016\/S1474-4422(08)70224-2","journal-title":"Lancet Neurol"},{"key":"3318_CR60","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","volume":"13","author":"N Gresa-Arribas","year":"2014","unstructured":"Gresa-Arribas N, Titulaer MJ, Torrents A et al (2014) Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 13:167\u2013177. https:\/\/doi.org\/10.1016\/S1474-4422(13)70282-5","journal-title":"Lancet Neurol"},{"key":"3318_CR61","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157\u2013165. https:\/\/doi.org\/10.1016\/S1474-4422(12)70310-1","journal-title":"Lancet Neurol"},{"key":"3318_CR62","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S2215-0366(19)30001-X","volume":"6","author":"A Al-Diwani","year":"2019","unstructured":"Al-Diwani A, Handel A, Townsend L et al (2019) The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. The lancet Psychiatry 6:235\u2013246. https:\/\/doi.org\/10.1016\/S2215-0366(19)30001-X","journal-title":"The lancet Psychiatry"},{"key":"3318_CR63","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","volume":"87","author":"H Ari\u00f1o","year":"2016","unstructured":"Ari\u00f1o H, Armangu\u00e9 T, Petit-Pedrol M et al (2016) Anti-LGI1-associated cognitive impairment: Presentation and long-term outcome. Neurology 87:759\u2013765. https:\/\/doi.org\/10.1212\/WNL.0000000000003009","journal-title":"Neurology"},{"key":"3318_CR64","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ana.23577","volume":"72","author":"SR Irani","year":"2012","unstructured":"Irani SR, Pettingill P, Kleopa KA et al (2012) Morvan syndrome: clinical and serological observations in 29 cases. Ann Neurol 72:241\u2013255. https:\/\/doi.org\/10.1002\/ana.23577","journal-title":"Ann Neurol"},{"key":"3318_CR65","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S1474-4422(13)70299-0","volume":"13","author":"M Petit-Pedrol","year":"2014","unstructured":"Petit-Pedrol M, Armangue T, Peng X et al (2014) Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 13:276\u2013286. https:\/\/doi.org\/10.1016\/S1474-4422(13)70299-0","journal-title":"Lancet Neurol"},{"key":"3318_CR66","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","volume":"88","author":"M Spatola","year":"2017","unstructured":"Spatola M, Petit-Pedrol M, Simabukuro MM et al (2017) Investigations in GABA(A) receptor antibody-associated encephalitis. Neurology 88:1012\u20131020. https:\/\/doi.org\/10.1212\/WNL.0000000000003713","journal-title":"Neurology"},{"key":"3318_CR67","doi-asserted-by":"publisher","unstructured":"Deng B, Cai M, Qiu Y, et al (2022) MRI Characteristics of Autoimmune Encephalitis With Autoantibodies to GABAA Receptor: A Case Series. Neurol Neuroimmunol neuroinflammation 9:. https:\/\/doi.org\/10.1212\/NXI.0000000000001158","DOI":"10.1212\/NXI.0000000000001158"},{"key":"3318_CR68","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","volume":"81","author":"R H\u00f6ftberger","year":"2013","unstructured":"H\u00f6ftberger R, Titulaer MJ, Sabater L et al (2013) Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 81:1500\u20131506. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a9585f","journal-title":"Neurology"},{"key":"3318_CR69","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","volume":"9","author":"E Lancaster","year":"2010","unstructured":"Lancaster E, Lai M, Peng X et al (2010) Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9:67\u201376. https:\/\/doi.org\/10.1016\/S1474-4422(09)70324-2","journal-title":"Lancet Neurol"},{"key":"3318_CR70","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s00415-018-9153-8","volume":"266","author":"O Laurido-Soto","year":"2019","unstructured":"Laurido-Soto O, Brier MR, Simon LE et al (2019) Patient characteristics and outcome associations in AMPA receptor encephalitis. J Neurol 266:450\u2013460. https:\/\/doi.org\/10.1007\/s00415-018-9153-8","journal-title":"J Neurol"},{"key":"3318_CR71","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1212\/WNL.0000000000002775","volume":"86","author":"N Gresa-Arribas","year":"2016","unstructured":"Gresa-Arribas N, Planagum\u00e0 J, Petit-Pedrol M et al (2016) Human neurexin-3\u03b1 antibodies associate with encephalitis and alter synapse development. Neurology 86:2235\u20132242. https:\/\/doi.org\/10.1212\/WNL.0000000000002775","journal-title":"Neurology"},{"key":"3318_CR72","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"Sabater L, Gaig C, Gelpi E et al (2014) A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 13:575\u2013586. https:\/\/doi.org\/10.1016\/S1474-4422(14)70051-1","journal-title":"Lancet Neurol"},{"key":"3318_CR73","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","volume":"88","author":"C Gaig","year":"2017","unstructured":"Gaig C, Graus F, Compta Y et al (2017) Clinical manifestations of the anti-IgLON5 disease. Neurology 88:1736\u20131743. https:\/\/doi.org\/10.1212\/WNL.0000000000003887","journal-title":"Neurology"},{"key":"3318_CR74","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1212\/WNL.0000000000003796","volume":"88","author":"M Hara","year":"2017","unstructured":"Hara M, Ari\u00f1o H, Petit-Pedrol M et al (2017) DPPX antibody-associated encephalitis: Main syndrome and antibody effects. Neurology 88:1340\u20131348. https:\/\/doi.org\/10.1212\/WNL.0000000000003796","journal-title":"Neurology"},{"key":"3318_CR75","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/ana.23756","volume":"73","author":"A Boronat","year":"2013","unstructured":"Boronat A, Gelfand JM, Gresa-Arribas N et al (2013) Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol 73:120\u2013128. https:\/\/doi.org\/10.1002\/ana.23756","journal-title":"Ann Neurol"},{"key":"3318_CR76","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0000000000001907","volume":"85","author":"J Piepgras","year":"2015","unstructured":"Piepgras J, H\u00f6ltje M, Michel K et al (2015) Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons. Neurology 85:890\u2013897. https:\/\/doi.org\/10.1212\/WNL.0000000000001907","journal-title":"Neurology"},{"key":"3318_CR77","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1093\/brain\/aws256","volume":"135","author":"RC Dale","year":"2012","unstructured":"Dale RC, Merheb V, Pillai S et al (2012) Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 135:3453\u20133468. https:\/\/doi.org\/10.1093\/brain\/aws256","journal-title":"Brain"},{"key":"3318_CR78","doi-asserted-by":"publisher","first-page":"e1964","DOI":"10.1212\/WNL.0000000000005614","volume":"90","author":"M Spatola","year":"2018","unstructured":"Spatola M, Sabater L, Planagum\u00e0 J et al (2018) Encephalitis with mGluR5 antibodies: Symptoms and antibody effects. Neurology 90:e1964\u2013e1972. https:\/\/doi.org\/10.1212\/WNL.0000000000005614","journal-title":"Neurology"},{"key":"3318_CR79","doi-asserted-by":"publisher","first-page":"e3012","DOI":"10.1212\/WNL.0000000000010854","volume":"95","author":"M Spatola","year":"2020","unstructured":"Spatola M, Petit Pedrol M, Maudes E et al (2020) Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis. Neurology 95:e3012\u2013e3025. https:\/\/doi.org\/10.1212\/WNL.0000000000010854","journal-title":"Neurology"},{"key":"3318_CR80","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/ana.26098","volume":"90","author":"J Landa","year":"2021","unstructured":"Landa J, Guasp M, M\u00edguez-Cabello F et al (2021) Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2. Ann Neurol 90:101\u2013117. https:\/\/doi.org\/10.1002\/ana.26098","journal-title":"Ann Neurol"},{"key":"3318_CR81","doi-asserted-by":"publisher","unstructured":"Landa J, Guasp M, Petit-Pedrol M, et al (2021) Seizure-related 6 homolog like 2 autoimmunity: Neurologic syndrome and antibody effects. Neurol Neuroimmunol neuroinflammation 8:. https:\/\/doi.org\/10.1212\/NXI.0000000000000916","DOI":"10.1212\/NXI.0000000000000916"},{"key":"3318_CR82","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/brain\/83.3.357","volume":"83","author":"JB Brierly","year":"1960","unstructured":"Brierly JB, Corsellis JAN, Hierons R, Nevin S (1960) Subacute encephalitis of later adult life mainly affecting the limbic areas. Brain 83:357\u2013368. https:\/\/doi.org\/10.1093\/brain\/83.3.357","journal-title":"Brain"},{"key":"3318_CR83","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0165-5728(88)90157-9","volume":"20","author":"J Kohler","year":"1988","unstructured":"Kohler J, Hufschmidt A, Hermle L et al (1988) Limbic encephalitis: two cases. J Neuroimmunol 20:177\u2013178. https:\/\/doi.org\/10.1016\/0165-5728(88)90157-9","journal-title":"J Neuroimmunol"},{"key":"3318_CR84","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/neuonc\/nou030","volume":"16","author":"J Dalmau","year":"2014","unstructured":"Dalmau J, Rosenfeld MR (2014) Autoimmune encephalitis update. Neuro Oncol 16:771\u2013778. https:\/\/doi.org\/10.1093\/neuonc\/nou030","journal-title":"Neuro Oncol"},{"key":"3318_CR85","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.3174\/ajnr.A4408","volume":"36","author":"AJ Da Rocha","year":"2015","unstructured":"Da Rocha AJ, Nunes RH, Maia ACM, Do Amaral LLF (2015) Recognizing autoimmune-mediated encephalitis in the differential diagnosis of limbic disorders. Am J Neuroradiol 36:2196\u20132205. https:\/\/doi.org\/10.3174\/ajnr.A4408","journal-title":"Am J Neuroradiol"},{"key":"3318_CR86","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ana.24979","volume":"82","author":"A Gadoth","year":"2017","unstructured":"Gadoth A, Pittock SJ, Dubey D et al (2017) Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients. Ann Neurol 82:79\u201392. https:\/\/doi.org\/10.1002\/ana.24979","journal-title":"Ann Neurol"},{"key":"3318_CR87","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/jamaneurol.2016.4226","volume":"74","author":"C Finke","year":"2017","unstructured":"Finke C, Pr\u00fcss H, Heine J et al (2017) Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies. JAMA Neurol 74:50\u201359. https:\/\/doi.org\/10.1001\/jamaneurol.2016.4226","journal-title":"JAMA Neurol"},{"key":"3318_CR88","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","volume":"87","author":"A van Sonderen","year":"2016","unstructured":"van Sonderen A, Thijs RD, Coenders EC et al (2016) Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up. Neurology 87:1449\u20131456. https:\/\/doi.org\/10.1212\/WNL.0000000000003173","journal-title":"Neurology"},{"key":"3318_CR89","doi-asserted-by":"publisher","unstructured":"Ghimire P, Khanal UP, Gajurel BP, et al (2020) Anti-LGI1, anti-GABABR, and Anti-CASPR2 encephalitides in Asia: A systematic review. Brain Behav 10:. https:\/\/doi.org\/10.1002\/brb3.1793","DOI":"10.1002\/brb3.1793"},{"key":"3318_CR90","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/jnnp-2017-315720","volume":"89","author":"SNM Binks","year":"2018","unstructured":"Binks SNM, Klein CJ, Waters P et al (2018) LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. J Neurol Neurosurg Psychiatry 89:526\u2013534. https:\/\/doi.org\/10.1136\/jnnp-2017-315720","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3318_CR91","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3389\/fneur.2020.00403","volume":"11","author":"F Zhu","year":"2020","unstructured":"Zhu F, Shan W, Lv R et al (2020) Clinical Characteristics of Anti-GABA-B Receptor Encephalitis. Front Neurol 11:403. https:\/\/doi.org\/10.3389\/fneur.2020.00403","journal-title":"Front Neurol"},{"key":"3318_CR92","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1017\/cjn.2016.13","volume":"43","author":"M-M Gagnon","year":"2016","unstructured":"Gagnon M-M, Savard M (2016) Limbic Encephalitis Associated With GAD65 Antibodies: Brief Review of the Relevant literature. Can J Neurol Sci Le J Can des Sci Neurol 43:486\u2013493. https:\/\/doi.org\/10.1017\/cjn.2016.13","journal-title":"Can J Neurol Sci Le J Can des Sci Neurol"},{"key":"3318_CR93","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/brain\/awq113","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Bera K, Waters P et al (2010) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655\u20131667. https:\/\/doi.org\/10.1093\/brain\/awq113","journal-title":"Brain"},{"key":"3318_CR94","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ana.21756","volume":"66","author":"NR Florance","year":"2009","unstructured":"Florance NR, Davis RL, Lam C et al (2009) Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 66:11\u201318. https:\/\/doi.org\/10.1002\/ana.21756","journal-title":"Ann Neurol"},{"key":"3318_CR95","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00234-006-0069-0","volume":"48","author":"H Urbach","year":"2006","unstructured":"Urbach H, Soeder BM, Jeub M et al (2006) Serial MRI of limbic encephalitis. Neuroradiology 48:380\u2013386. https:\/\/doi.org\/10.1007\/s00234-006-0069-0","journal-title":"Neuroradiology"},{"key":"3318_CR96","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1136\/jnnp-2014-307875","volume":"86","author":"J Wagner","year":"2015","unstructured":"Wagner J, Witt J-A, Helmstaedter C et al (2015) Automated volumetry of the mesiotemporal structures in antibody-associated limbic encephalitis. J Neurol Neurosurg Psychiatry 86:735\u2013742. https:\/\/doi.org\/10.1136\/jnnp-2014-307875","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3318_CR97","doi-asserted-by":"publisher","unstructured":"Guerin J, Watson RE, Carr CM, et al (2019) Autoimmune epilepsy: Findings on MRi and FDG-Pet. Br J Radiol 92:. https:\/\/doi.org\/10.1259\/bjr.20170869","DOI":"10.1259\/bjr.20170869"},{"key":"3318_CR98","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3174\/ajnr.A3633","volume":"35","author":"AL Kotsenas","year":"2014","unstructured":"Kotsenas AL, Watson RE, Pittock SJ et al (2014) MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis. AJNR Am J Neuroradiol 35:84\u201389. https:\/\/doi.org\/10.3174\/ajnr.A3633","journal-title":"AJNR Am J Neuroradiol"},{"key":"3318_CR99","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.3174\/ajnr.A6289","volume":"40","author":"L Ernst","year":"2019","unstructured":"Ernst L, David B, Gaubatz J et al (2019) Volumetry of Mesiotemporal Structures Reflects Serostatus in Patients with Limbic Encephalitis. AJNR Am J Neuroradiol 40:2081\u20132089. https:\/\/doi.org\/10.3174\/ajnr.A6289","journal-title":"AJNR Am J Neuroradiol"},{"key":"3318_CR100","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/ene.12249","volume":"20","author":"B Oyanguren","year":"2013","unstructured":"Oyanguren B, S\u00e1nchez V, Gonz\u00e1lez FJ et al (2013) Limbic encephalitis: a clinical-radiological comparison between herpetic and autoimmune etiologies. Eur J Neurol 20:1566\u20131570. https:\/\/doi.org\/10.1111\/ene.12249","journal-title":"Eur J Neurol"},{"key":"3318_CR101","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00062-018-0705-1","volume":"29","author":"A-H Schievelkamp","year":"2019","unstructured":"Schievelkamp A-H, Jurcoane A, R\u00fcber T et al (2019) Limbic Encephalitis in Patients with Epilepsy-is Quantitative MRI Diagnostic? Clin Neuroradiol 29:623\u2013630. https:\/\/doi.org\/10.1007\/s00062-018-0705-1","journal-title":"Clin Neuroradiol"},{"key":"3318_CR102","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1111\/epi.12320","volume":"54","author":"J Wagner","year":"2013","unstructured":"Wagner J, Schoene-Bake J-C, Malter MP et al (2013) Quantitative FLAIR analysis indicates predominant affection of the amygdala in antibody-associated limbic encephalitis. Epilepsia 54:1679\u20131687. https:\/\/doi.org\/10.1111\/epi.12320","journal-title":"Epilepsia"},{"key":"3318_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2020.618109","volume":"11","author":"X Shao","year":"2021","unstructured":"Shao X, Fan S, Luo H et al (2021) Brain Magnetic Resonance Imaging Characteristics of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis and Their Clinical Relevance: A Single-Center Study in China. Front Neurol 11:1\u201310. https:\/\/doi.org\/10.3389\/fneur.2020.618109","journal-title":"Front Neurol"},{"key":"3318_CR104","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3174\/ajnr.A7907","volume":"44","author":"S Gillon","year":"2023","unstructured":"Gillon S, Chan M, Chen J et al (2023) MR Imaging Findings in a Large Population of Autoimmune Encephalitis. AJNR Am J Neuroradiol 44:799\u2013806. https:\/\/doi.org\/10.3174\/ajnr.A7907","journal-title":"AJNR Am J Neuroradiol"},{"key":"3318_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinimag.2021.12.011","volume":"84","author":"C Ball","year":"2022","unstructured":"Ball C, Fisicaro R, Morris L 3rd et al (2022) Brain on fire: an imaging-based review of autoimmune encephalitis. Clin Imaging 84:1\u201330. https:\/\/doi.org\/10.1016\/j.clinimag.2021.12.011","journal-title":"Clin Imaging"},{"key":"3318_CR106","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s00415-015-7818-0","volume":"262","author":"D Renard","year":"2015","unstructured":"Renard D, Nerrant E, Lechiche C (2015) DWI and FLAIR imaging in herpes simplex encephalitis: a comparative and topographical analysis. J Neurol 262:2101\u20132105. https:\/\/doi.org\/10.1007\/s00415-015-7818-0","journal-title":"J Neurol"},{"key":"3318_CR107","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neuroscience.2015.05.037","volume":"309","author":"J Heine","year":"2015","unstructured":"Heine J, Pr\u00fcss H, Bartsch T et al (2015) Imaging of autoimmune encephalitis - Relevance for clinical practice and hippocampal function. Neuroscience 309:68\u201383. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.05.037","journal-title":"Neuroscience"},{"key":"3318_CR108","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s10072-021-05617-0","volume":"43","author":"H Elkhider","year":"2022","unstructured":"Elkhider H, Sharma R, Kapoor N et al (2022) Autoimmune encephalitis and seizures, cerebrospinal fluid, imaging, and EEG findings: a case series. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 43:2669\u20132680. https:\/\/doi.org\/10.1007\/s10072-021-05617-0","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"3318_CR109","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1007\/s00415-013-7048-2","volume":"260","author":"A Baumgartner","year":"2013","unstructured":"Baumgartner A, Rauer S, Mader I, Meyer PT (2013) Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol 260:2744\u20132753. https:\/\/doi.org\/10.1007\/s00415-013-7048-2","journal-title":"J Neurol"},{"key":"3318_CR110","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/s0895-6111(02)00022-8","volume":"26","author":"RN Sener","year":"2002","unstructured":"Sener RN (2002) MRI and diffusion MRI in nonparaneoplastic limbic encephalitis. Comput Med imaging Graph Off J Comput Med Imaging Soc 26:339\u2013342. https:\/\/doi.org\/10.1016\/s0895-6111(02)00022-8","journal-title":"Comput Med imaging Graph Off J Comput Med Imaging Soc"},{"key":"3318_CR111","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1007\/s00415-020-10007-1","volume":"267","author":"A Budhram","year":"2020","unstructured":"Budhram A, Britton JW, Liebo GB et al (2020) Use of diffusion-weighted imaging to distinguish seizure-related change from limbic encephalitis. J Neurol 267:3337\u20133342. https:\/\/doi.org\/10.1007\/s00415-020-10007-1","journal-title":"J Neurol"},{"issue":"Suppl 4","key":"3318_CR112","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1528-1167.2012.03610.x","volume":"53","author":"K Malmgren","year":"2012","unstructured":"Malmgren K, Thom M (2012) Hippocampal sclerosis\u2013origins and imaging. Epilepsia 53(Suppl 4):19\u201333. https:\/\/doi.org\/10.1111\/j.1528-1167.2012.03610.x","journal-title":"Epilepsia"},{"key":"3318_CR113","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0887-8994(94)00122-i","volume":"12","author":"Z Liu","year":"1995","unstructured":"Liu Z, Mikati M, Holmes GL (1995) Mesial temporal sclerosis: pathogenesis and significance. Pediatr Neurol 12:5\u201316. https:\/\/doi.org\/10.1016\/0887-8994(94)00122-i","journal-title":"Pediatr Neurol"},{"key":"3318_CR114","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.seizure.2017.07.006","volume":"51","author":"S Popkirov","year":"2017","unstructured":"Popkirov S, Ismail FS, Gr\u00f6nheit W et al (2017) Progressive hippocampal sclerosis after viral encephalitis: Potential role of NMDA receptor antibodies. Seizure 51:6\u20138. https:\/\/doi.org\/10.1016\/j.seizure.2017.07.006","journal-title":"Seizure"},{"key":"3318_CR115","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1111\/epi.14534","volume":"59","author":"AW N\u00f3brega-Jr","year":"2018","unstructured":"N\u00f3brega-Jr AW, Gregory CP, Schlindwein-Zanini R et al (2018) Mesial temporal lobe epilepsy with hippocampal sclerosis is infrequently associated with neuronal autoantibodies. Epilepsia 59:e152\u2013e156. https:\/\/doi.org\/10.1111\/epi.14534","journal-title":"Epilepsia"},{"key":"3318_CR116","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1007\/s00259-021-05299-y","volume":"48","author":"M Bordonne","year":"2021","unstructured":"Bordonne M, Chawki MB, Doyen M et al (2021) Brain (18)F-FDG PET for the diagnosis of autoimmune encephalitis: a systematic review and a meta-analysis. Eur J Nucl Med Mol Imaging 48:3847\u20133858. https:\/\/doi.org\/10.1007\/s00259-021-05299-y","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3318_CR117","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3174\/ajnr.A5593","volume":"39","author":"T Zhang","year":"2018","unstructured":"Zhang T, Duan Y, Ye J et al (2018) Brain MRI Characteristics of Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Their Associations with 2-Year Clinical Outcome. AJNR Am J Neuroradiol 39:824\u2013829. https:\/\/doi.org\/10.3174\/ajnr.A5593","journal-title":"AJNR Am J Neuroradiol"},{"key":"3318_CR118","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000322","volume":"4","author":"R Ogawa","year":"2017","unstructured":"Ogawa R, Nakashima I, Takahashi T et al (2017) MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy. Neurol Neuroimmunol Neuroinflammation 4:e322. https:\/\/doi.org\/10.1212\/NXI.0000000000000322","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"3318_CR119","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/jnnp-2016-315094","volume":"88","author":"J Fujimori","year":"2017","unstructured":"Fujimori J, Takai Y, Nakashima I et al (2017) Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies. J Neurol Neurosurg Psychiatry 88:534\u2013536","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3318_CR120","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","volume":"73","author":"B Fang","year":"2016","unstructured":"Fang B, McKeon A, Hinson SR et al (2016) Autoimmune glial fibrillary acidic protein astrocytopathy: A novel meningoencephalomyelitis. JAMA Neurol 73:1297\u20131307. https:\/\/doi.org\/10.1001\/jamaneurol.2016.2549","journal-title":"JAMA Neurol"},{"key":"3318_CR121","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","volume":"49","author":"Z Yu","year":"2001","unstructured":"Yu Z, Kryzer TJ, Griesmann GE et al (2001) CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 49:146\u2013154","journal-title":"Ann Neurol"},{"key":"3318_CR122","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.radcr.2017.06.004","volume":"12","author":"JR Sachs","year":"2017","unstructured":"Sachs JR, Zapadka ME, Popli GS, Burdette JH (2017) Arterial spin labeling perfusion imaging demonstrates cerebral hyperperfusion in anti-NMDAR encephalitis. Radiol Case Reports 12:833\u2013837. https:\/\/doi.org\/10.1016\/j.radcr.2017.06.004","journal-title":"Radiol Case Reports"},{"key":"3318_CR123","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1056\/NEJMcpc1802824","volume":"379","author":"MP Gorman","year":"2018","unstructured":"Gorman MP, Gombolay GY, Mehan WAJ, Thibert RL (2018) Case 27\u20132018: A 3-Year-Old Boy with Seizures. N Engl J Med 379:870\u2013878. https:\/\/doi.org\/10.1056\/NEJMcpc1802824","journal-title":"N Engl J Med"},{"key":"3318_CR124","doi-asserted-by":"publisher","unstructured":"Flanagan EP, Kotsenas AL, Britton JW, et al (2015) Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic Seizures. Neurol Neuroimmunol NeuroInflammation 2:. https:\/\/doi.org\/10.1212\/NXI.0000000000000161","DOI":"10.1212\/NXI.0000000000000161"},{"key":"3318_CR125","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/jnnp.2008.158246","volume":"80","author":"A Saiz","year":"2009","unstructured":"Saiz A, Bruna J, Stourac P et al (2009) Anti-Hu-associated brainstem encephalitis. J Neurol Neurosurg Psychiatry 80:404\u2013407. https:\/\/doi.org\/10.1136\/jnnp.2008.158246","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3318_CR126","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1001\/jamaneurol.2020.2231","volume":"77","author":"D Dubey","year":"2020","unstructured":"Dubey D, Wilson MR, Clarkson B et al (2020) Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis. JAMA Neurol 77:1420\u20131429. https:\/\/doi.org\/10.1001\/jamaneurol.2020.2231","journal-title":"JAMA Neurol"},{"key":"3318_CR127","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/ana.20614","volume":"58","author":"R Vitaliani","year":"2005","unstructured":"Vitaliani R, Mason W, Ances B et al (2005) Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 58:594\u2013604. https:\/\/doi.org\/10.1002\/ana.20614","journal-title":"Ann Neurol"},{"key":"3318_CR128","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1177\/0883073811405199","volume":"26","author":"M Maqbool","year":"2011","unstructured":"Maqbool M, Oleske DA, Huq AHM et al (2011) Novel FDG-PET findings in anti-NMDA receptor encephalitis: a case based report. J Child Neurol 26:1325\u20131328. https:\/\/doi.org\/10.1177\/0883073811405199","journal-title":"J Child Neurol"},{"key":"3318_CR129","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/mds.25626","volume":"29","author":"Y Hacohen","year":"2014","unstructured":"Hacohen Y, Deiva K, Pettingill P et al (2014) N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Mov Disord 29:90\u201396. https:\/\/doi.org\/10.1002\/mds.25626","journal-title":"Mov Disord"},{"key":"3318_CR130","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/cid\/civ051","volume":"60","author":"FC Chow","year":"2015","unstructured":"Chow FC, Glaser CA, Sheriff H et al (2015) Use of clinical and neuroimaging characteristics to distinguish temporal lobe herpes simplex encephalitis from its mimics. Clin Infect Dis an Off Publ Infect Dis Soc Am 60:1377\u20131383. https:\/\/doi.org\/10.1093\/cid\/civ051","journal-title":"Clin Infect Dis an Off Publ Infect Dis Soc Am"},{"key":"3318_CR131","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/WCO.0000000000000087","volume":"27","author":"T Armangue","year":"2014","unstructured":"Armangue T, Leypoldt F, Dalmau J (2014) Autoimmune encephalitis as differential diagnosis of infectious encephalitis. Curr Opin Neurol 27:361\u2013368. https:\/\/doi.org\/10.1097\/WCO.0000000000000087","journal-title":"Curr Opin Neurol"},{"key":"3318_CR132","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.2147\/NDT.S274487","volume":"16","author":"CN Huang","year":"2020","unstructured":"Huang CN, Tian XB, Jiang SM et al (2020) Comparisons between infectious and autoimmune encephalitis: Clinical signs, biochemistry, blood counts, and imaging findings. Neuropsychiatr Dis Treat 16:2649\u20132660. https:\/\/doi.org\/10.2147\/NDT.S274487","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3318_CR133","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1055\/s-0039-1687838","volume":"39","author":"A Venkatesan","year":"2019","unstructured":"Venkatesan A, Jagdish B (2019) Imaging in Encephalitis. Semin Neurol 39:312\u2013321. https:\/\/doi.org\/10.1055\/s-0039-1687838","journal-title":"Semin Neurol"},{"key":"3318_CR134","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","volume":"17","author":"T Armangue","year":"2018","unstructured":"Armangue T, Spatola M, Vlagea A et al (2018) Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol 17:760\u2013772. https:\/\/doi.org\/10.1016\/S1474-4422(18)30244-8","journal-title":"Lancet Neurol"},{"key":"3318_CR135","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1007\/s00415-021-10738-9","volume":"269","author":"MS Nissen","year":"2022","unstructured":"Nissen MS, \u00d8rvik MS, Nilsson AC et al (2022) NMDA-receptor encephalitis in Denmark from 2009 to 2019: a national cohort study. J Neurol 269:1618\u20131630. https:\/\/doi.org\/10.1007\/s00415-021-10738-9","journal-title":"J Neurol"},{"key":"3318_CR136","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.autrev.2016.09.008","volume":"15","author":"C Laurent","year":"2016","unstructured":"Laurent C, Capron J, Quillerou B et al (2016) Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): Characteristics, treatment and outcome in 251 cases from the literature. Autoimmun Rev 15:1129\u20131133. https:\/\/doi.org\/10.1016\/j.autrev.2016.09.008","journal-title":"Autoimmun Rev"},{"key":"3318_CR137","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1212\/WNL.0000000000008785","volume":"94","author":"S Mattozzi","year":"2020","unstructured":"Mattozzi S, Sabater L, Escudero D et al (2020) Hashimoto encephalopathy in the 21st century. Neurology 94:e217\u2013e224. https:\/\/doi.org\/10.1212\/WNL.0000000000008785","journal-title":"Neurology"},{"key":"3318_CR138","doi-asserted-by":"publisher","first-page":"204798161455221","DOI":"10.1177\/2047981614552218","volume":"3","author":"M Bozluolcay","year":"2014","unstructured":"Bozluolcay M, Elmali AD, Menku SF et al (2014) Magnetic resonance imaging findings in probable Creutzfeld-Jacob disease: comparison with electroencephalography and cerebrospinal fluid characteristics. Acta Radiol short reports 3:2047981614552218. https:\/\/doi.org\/10.1177\/2047981614552218","journal-title":"Acta Radiol short reports"},{"key":"3318_CR139","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s11910-011-0228-5","volume":"11","author":"B Jubelt","year":"2011","unstructured":"Jubelt B, Mihai C, Li TM, Veerapaneni P (2011) Rhombencephalitis \/ brainstem encephalitis. Curr Neurol Neurosci Rep 11:543\u2013552. https:\/\/doi.org\/10.1007\/s11910-011-0228-5","journal-title":"Curr Neurol Neurosci Rep"},{"key":"3318_CR140","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189. https:\/\/doi.org\/10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"key":"3318_CR141","doi-asserted-by":"publisher","unstructured":"Saleem SN, Said A-HM, Lee DH (2007) Lesions of the hypothalamus: MR imaging diagnostic features. Radiogr a Rev Publ Radiol Soc North Am Inc 27:1087\u20131108. https:\/\/doi.org\/10.1148\/rg.274065123","DOI":"10.1148\/rg.274065123"},{"key":"3318_CR142","doi-asserted-by":"publisher","first-page":"e1948","DOI":"10.1212\/WNL.0000000000207830","volume":"101","author":"A Costa","year":"2023","unstructured":"Costa A, Silva C, Taipa R et al (2023) Teaching NeuroImage: Perivascular Radial Enhancement in Neurosarcoidosis. Neurology 101:e1948\u2013e1949. https:\/\/doi.org\/10.1212\/WNL.0000000000207830","journal-title":"Neurology"},{"key":"3318_CR143","doi-asserted-by":"publisher","first-page":"907.e15","DOI":"10.1016\/j.crad.2018.05.018","volume":"73","author":"G Bathla","year":"2018","unstructured":"Bathla G, Watal P, Gupta S et al (2018) Cerebrovascular manifestations in neurosarcoidosis: how common are they and does perivascular enhancement matter? Clin Radiol 73:907.e15-907.e23. https:\/\/doi.org\/10.1016\/j.crad.2018.05.018","journal-title":"Clin Radiol"},{"key":"3318_CR144","first-page":"1283","volume":"22","author":"U Tateishi","year":"2001","unstructured":"Tateishi U, Terae S, Ogata A et al (2001) MR imaging of the brain in lymphomatoid granulomatosis. AJNR Am J Neuroradiol 22:1283\u20131290","journal-title":"AJNR Am J Neuroradiol"},{"key":"3318_CR145","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.wneu.2020.05.194","volume":"140","author":"IE Efe","year":"2020","unstructured":"Efe IE, Aydin OU, Alabulut A et al (2020) COVID-19-Associated Encephalitis Mimicking Glial Tumor. World Neurosurg 140:46\u201348","journal-title":"World Neurosurg"},{"key":"3318_CR146","doi-asserted-by":"publisher","unstructured":"Stoian A, Stoian M, Bajko Z, et al (2022) Autoimmune Encephalitis in COVID-19 Infection: Our Experience and Systematic Review of the Literature. Biomedicines 10:. https:\/\/doi.org\/10.3390\/biomedicines10040774","DOI":"10.3390\/biomedicines10040774"},{"key":"3318_CR147","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00415-018-8767-1","volume":"265","author":"A Vogrig","year":"2018","unstructured":"Vogrig A, Joubert B, Ducray F et al (2018) Glioblastoma as differential diagnosis of autoimmune encephalitis. J Neurol 265:669\u2013677. https:\/\/doi.org\/10.1007\/s00415-018-8767-1","journal-title":"J Neurol"},{"key":"3318_CR148","doi-asserted-by":"publisher","unstructured":"Van Steenhoven RW, de Vries JM, Bruijstens AL, et al (2023) Mimics of Autoimmune Encephalitis: Validation of the 2016 Clinical Autoimmune Encephalitis Criteria. Neurol Neuroimmunol neuroinflammation 10:. https:\/\/doi.org\/10.1212\/NXI.0000000000200148","DOI":"10.1212\/NXI.0000000000200148"},{"key":"3318_CR149","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","volume":"92","author":"H Abboud","year":"2021","unstructured":"Abboud H, Probasco JC, Irani S et al (2021) Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry 92:757\u2013768. https:\/\/doi.org\/10.1136\/jnnp-2020-325300","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3318_CR150","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/imj.12749","volume":"45","author":"PN Britton","year":"2015","unstructured":"Britton PN, Eastwood K, Paterson B et al (2015) Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand. Intern Med J 45:563\u2013576. https:\/\/doi.org\/10.1111\/imj.12749","journal-title":"Intern Med J"},{"key":"3318_CR151","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11060-016-2185-y","volume":"129","author":"CH Suh","year":"2016","unstructured":"Suh CH, Jung SC, Kim KW, Pyo J (2016) The detectability of brain metastases using contrast-enhanced spin-echo or gradient-echo images: a systematic review and meta-analysis. J Neurooncol 129:363\u2013371. https:\/\/doi.org\/10.1007\/s11060-016-2185-y","journal-title":"J Neurooncol"},{"key":"3318_CR152","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/neuonc\/noaa030","volume":"22","author":"TJ Kaufmann","year":"2020","unstructured":"Kaufmann TJ, Smits M, Boxerman J et al (2020) Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases. Neuro Oncol 22:757\u2013772. https:\/\/doi.org\/10.1093\/neuonc\/noaa030","journal-title":"Neuro Oncol"},{"key":"3318_CR153","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jinf.2011.11.014","volume":"64","author":"T Solomon","year":"2012","unstructured":"Solomon T, Michael BD, Smith PE et al (2012) Management of suspected viral encephalitis in adults\u2013Association of British Neurologists and British Infection Association National Guidelines. J Infect 64:347\u2013373. https:\/\/doi.org\/10.1016\/j.jinf.2011.11.014","journal-title":"J Infect"},{"key":"3318_CR154","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s40336-018-0275-x","volume":"6","author":"S Morbelli","year":"2018","unstructured":"Morbelli S, Zoccarato M, Bauckneht M et al (2018) 18F-FDG-PET and MRI in autoimmune encephalitis: a systematic review of brain findings. Clin Transl Imaging 6:151\u2013168. https:\/\/doi.org\/10.1007\/s40336-018-0275-x","journal-title":"Clin Transl Imaging"},{"key":"3318_CR155","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1468-1331.2010.03220.x","volume":"18","author":"MJ Titulaer","year":"2011","unstructured":"Titulaer MJ, Soffietti R, Dalmau J et al (2011) Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol 18:19-e3. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03220.x","journal-title":"Eur J Neurol"},{"key":"3318_CR156","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1212\/01.wnl.0000252379.81933.80","volume":"68","author":"RM Mathew","year":"2007","unstructured":"Mathew RM, Vandenberghe R, Garcia-Merino A et al (2007) Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis. Neurology 68:900\u2013905. https:\/\/doi.org\/10.1212\/01.wnl.0000252379.81933.80","journal-title":"Neurology"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-024-03318-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00234-024-03318-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-024-03318-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T21:03:36Z","timestamp":1713560616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00234-024-03318-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":156,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["3318"],"URL":"https:\/\/doi.org\/10.1007\/s00234-024-03318-x","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"assertion":[{"value":"15 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no editorial positions in this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Editorial Board Members and Editors"}},{"value":"The authors have no relevant employment to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Employment"}},{"value":"FM received speaker honorarium from Roche Diagnostic S.p.A. MG received honoraria for the participation to advisory boards from Roche and UCB. The other authors have no relevant financial interests to disclose.The authors have no relevant non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest \/ Competing interests"}},{"value":"The images shown were obtained from patients who gave written informed consent to have their data used for research purposes. No images that can lead to subject identification are included in this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Patients gave written informed consent to have their data used for research purposes.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}